MTOR and cancer: Previous observations highlight the significant role of mTOR signaling in mediating therapy resistance of cancer cells via entering a diapause-like dormant state depending on mTOR inhibition and autophagy activation, the same way as diapaused mESCs adapt and survive unfavorable conditions.